← Browse by Condition
Medical Condition

mitral valve replacement

Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for mitral valve replacement sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — mitral valve replacement Clinical Trials

How many clinical trials are currently recruiting for mitral valve replacement?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for mitral valve replacement, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for mitral valve replacement?
mitral valve replacement research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a mitral valve replacement clinical trial?
Eligibility criteria for mitral valve replacement trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
ReValve Solutions Inc. 1 trial
Abbott Medical Devices 1 trial

Recruiting Clinical Trials

NCT07601269 EARLY_Phase 1
Recruiting
Replacement of the Native Mitral Valve Using the ReValve System
Enrollment
25 pts
Location
Brazil
Sponsor
ReValve Solutions Inc.
View Trial →
NCT07069673
Recruiting
Abbott Cephea Mitral Valve Disease Registry
Enrollment
1,000 pts
Location
United States
Sponsor
Abbott Medical Devices
View Trial →

Related Conditions

mitral regurgitation (1) mitral stenosis (1) mitral valve disease (1) mitral valve mv regurgitation (1) mitral annulus calcification (1) transcatheter valve replacement (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology